연구성과로 돌아가기
2023 연구자 정보 (61 / 1135)
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Author Name | 제1저자 여부 | 교신저자 여부 | Address | ResearcherID | ORCID | Paper Title | WoS Edition | 최상위 JCR(%) | WoS Category | Related Email |
|---|---|---|---|---|---|---|---|---|---|---|
|
Kim, Mimi (Kim, M) |
제1저자 | Hanyang Univ, Coll Med, Seoul, South Korea |
G-5001-2015 Kim, Chang |
|
[JCR상위 1.7] The role of M2BPGi in screening for advanced hepatic fibrosis in diabetic patients [JCR상위 1.7] The role of M2BPGi for screening of advanced hepatic fibrosis in elderly patients [JCR상위 1.7] Fibrosis-4 and M2BPGi combination screening algorithm for screening advanced hepatic fibrosis in diabetes is cost-effective |
SCIE | 1.7 | GASTROENTEROLOGY & HEPATOLOGY | noshin@hanyang.ac.kr; | |
|
Kim, Min Kyoon (Kim, MK) |
|
|
[JCR상위 1.7] Omission of breast surgery for predicted pCR patients with MRI and vacuum-assisted biopsy in breast cancer after neoadjuvant chemotherapy: A multicenter, single-arm, non-inferiority trial (OPTIMIST trial) | SCIE | 1.7 | ONCOLOGY | ||||
|
Kim, Soo-Yeon (Kim, SY) |
J-5441-2012 Kim, Jee |
|
[JCR상위 1.7] Omission of breast surgery for predicted pCR patients with MRI and vacuum-assisted biopsy in breast cancer after neoadjuvant chemotherapy: A multicenter, single-arm, non-inferiority trial (OPTIMIST trial) | SCIE | 1.7 | ONCOLOGY | ||||
|
Kim, Tae-Yong (Kim, TY) |
Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea |
C-1272-2009 Kim, Tae |
|
[JCR상위 1.7] ATTRACTION-5: A phase 3 study of nivolumab plus chemotherapy as postoperative adjuvant treatment for pathological stage III (pStage III) gastric or gastroesophageal junction (G/GEJ) cancer [JCR상위 34.6] Korean Practice Guidelines for Gastric Cancer 2022: An Evidence-based, Multidisciplinary Approach [JCR상위 34.6] Korean Practice Guidelines for Gastric Cancer 2022: An Evidence-based, Multidisciplinary Approach (vol 23, pg 3, 2023) |
SCIE | 1.7 |
ONCOLOGY GASTROENTEROLOGY & HEPATOLOGY;ONCOLOGY |
hyesukhan@chungbuk.ac.kr;nam20131114@gmail.com;seongho.kong@snu.ac.kr; | ||
|
Ko, Bor-Sheng (Ko, BS) |
Natl Taiwan Univ Hosp, Dept Internal Med, Taipei, Taiwan |
|
|
[JCR상위 1.7] Ibrutinib for First-Line Treatment of Chronic Graft-Versus-Host Disease: Results From the Randomized Phase III iNTEGRATE Study | SCIE | 1.7 | ONCOLOGY | dmiklos@stanford.edu; | ||
|
Koh, Jiwon (Koh, J) |
|
|
[JCR상위 1.7] Omission of breast surgery for predicted pCR patients with MRI and vacuum-assisted biopsy in breast cancer after neoadjuvant chemotherapy: A multicenter, single-arm, non-inferiority trial (OPTIMIST trial) | SCIE | 1.7 | ONCOLOGY | ||||
|
Komura, Takuya (Komura, T) |
Kanazawa Med Ctr, Kanazawa, Ishikawa, Japan |
|
|
[JCR상위 1.7] Evidence of durable response to bepirovirsen in B-Clear responders: B-Sure first annual report | SCIE | 1.7 | GASTROENTEROLOGY & HEPATOLOGY | robert.c.elston@gsk.com; | ||
|
Kook, Yoonwon (Kook, Y) |
|
|
[JCR상위 1.7] Prospective single-arm study of endocrine therapies with ovarian function suppression in premenopausal patients with node-positive early breast cancer with low genomic risk (INTERSTELLAR trial, KBCSG-25) | SCIE | 1.7 | ONCOLOGY | ||||
|
Koustenis, Andrew (Koustenis, A) |
|
|
[JCR상위 1.7] Phase 2 study of bavituximab (bavi), a first-in-class antibody targeting phosphatidylserine (PS), plus pembrolizumab (P) in advanced gastric or gastroesophageal junction (GEJ) cancer | SCIE | 1.7 | ONCOLOGY | ||||
|
Kudo, Masatoshi (Kudo, M) |
Kindai Univ, Osaka, Japan |
AAA-9744-2019 Kudo, Masatoshi |
|
[JCR상위 1.7] Outcomes by occurrence of immune-mediated adverse events (imAEs) with tremelimumab (T) plus durvalumab (D) in the phase 3 HIMALAYA study in unresectable hepatocellular carcinoma (uHCC) [JCR상위 0.2] Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3trial |
SCIE | 0.2 |
ONCOLOGY MEDICINE, GENERAL & INTERNAL |
pierce.chow@duke-nus.edu.sg; | ||
|
Kuswidiyanto, Lukas Wiku (Kuswidiyanto, LW) |
제1저자 | Kangwon Natl Univ, Coll Agr & Life Sci, Interdisciplinary Program Smart Agr, Chunchon, South Korea |
|
|
[JCR상위 1.7] Airborne hyperspectral imaging for early diagnosis of kimchi cabbage downy mildew using 3D-ResNet and leaf segmentation | SCIE | 1.7 | AGRICULTURE, MULTIDISCIPLINARY;COMPUTER SCIENCE, INTERDISCIPLINARY APPLICATIONS | hanxiongzhe@kangwon.ac.kr; | |
|
Kuwahara, Yusuke (Kuwahara, Y) |
|
|
[JCR상위 1.7] Trastuzumab deruxtecan (T-DXd) vs treatment of physician's choice (TPC) in patients (pts) with HER2-low, hormone receptor-positive (HR plus ) unresectable and/or metastatic breast cancer (mBC): Exploratory biomarker analysis of DESTINY-Breast04 | SCIE | 1.7 | ONCOLOGY | ||||
|
Kwon, Hyuk-Jun (Kwon, HJ) |
교신저자 |
DGIST, Dept Elect Engn & Comp Sci, Daegu 42988, South Korea DGIST, Convergence Res Adv Ctr Olfact, Daegu 42988, South Korea |
|
0000-0002-4767-7444 Kwon, Hyuk-Jun |
[JCR상위 1.7] Schottky barrier modulation of bottom contact SnO2 thin-film transistors via chloride-based combustion synthesis | SCIE | 1.7 | MATERIALS SCIENCE, MULTIDISCIPLINARY;METALLURGY & METALLURGICAL ENGINEERING | hj.kwon@dgist.ac.kr; | |
|
Lau, George (Lau, G) |
제1저자 |
AAQ-2085-2021 Lau, George |
|
[JCR상위 1.7] Outcomes by occurrence of immune-mediated adverse events (imAEs) with tremelimumab (T) plus durvalumab (D) in the phase 3 HIMALAYA study in unresectable hepatocellular carcinoma (uHCC) | SCIE | 1.7 | ONCOLOGY | |||
|
Lee, Han-Byoel (Lee, HB) |
|
|
[JCR상위 1.7] Prospective single-arm study of endocrine therapies with ovarian function suppression in premenopausal patients with node-positive early breast cancer with low genomic risk (INTERSTELLAR trial, KBCSG-25) [JCR상위 1.7] Omission of breast surgery for predicted pCR patients with MRI and vacuum-assisted biopsy in breast cancer after neoadjuvant chemotherapy: A multicenter, single-arm, non-inferiority trial (OPTIMIST trial) |
SCIE | 1.7 | ONCOLOGY |
페이지 이동: